Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:APOP

Cellect Biotechnology (APOP) Stock Price, News & Analysis

Cellect Biotechnology logo

About Cellect Biotechnology Stock (NASDAQ:APOP)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$7.54
$13.40
52-Week Range
N/A
Volume
17,400 shs
Average Volume
479,845 shs
Market Capitalization
$12.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive APOP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cellect Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

APOP Stock News Headlines

Americans are rushing into gold (but not billionaires!)
Billionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scrambling to buy gold coins and bars. But some savvy investors have used a different way to profit from gold bull runs — a special investment with a long history of making 13 times … 21 times … 157 times … even a surprising 1,000 times more than physical gold.
Krystal Biotech Inc.
Raleigh/Durham Biotech News
See More Headlines

APOP Stock Analysis - Frequently Asked Questions

Cellect Biotechnology Ltd. (NASDAQ:APOP) announced its quarterly earnings results on Tuesday, November, 13th. The company reported ($0.58) EPS for the quarter, missing the consensus estimate of ($0.56) by $0.02.

Cellect Biotechnology shares split on Tuesday, October 26th 2021.The 2-1 split was announced on Tuesday, October 26th 2021. The newly minted shares were distributed to shareholders after the market closes on Tuesday, October 26th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cellect Biotechnology investors own include Elbit Systems (ESLT), Gilead Sciences (GILD), Protalix BioTherapeutics (PLX), Advanced Micro Devices (AMD), NVIDIA (NVDA), Acasti Pharma (ACST) and Corbus Pharmaceuticals (CRBP).

Company Calendar

Last Earnings
11/13/2018
Today
8/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:APOP
CIK
1671502
Employees
2,020
Year Founded
2011

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.01
Quick Ratio
3.01

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.77 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
977,000
Free Float
N/A
Market Cap
$12.87 million
Optionable
Not Optionable
Beta
1.87

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:APOP) was last updated on 8/10/2025 by MarketBeat.com Staff
From Our Partners